Together, these diverse differences imply that STMN1 phosphorylation and activities are cell type- and growth factor-specific and that cancer-specific approaches will likely be required to effectively block STMN1 phosphorylation-mediated tumor cell growth and metastasis. The gene discussed is STMN1; the disease is neoplasm.